Alternative Data for Soligenix
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 343 | Sign up | Sign up | Sign up |
| Instagram Followers | 231 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 6 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 12,830 | Sign up | Sign up | Sign up |
| X Followers | 925 | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 775 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 25 | Sign up | Sign up | Sign up |
About Soligenix
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States.
| Price | $1.09 |
| Target Price | Sign up |
| Volume | 161,690 |
| Market Cap | $11M |
| Year Range | $1.04 - $4.96 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
12 Health Care Stocks Moving In Monday's Pre-Market SessionFebruary 8 - Benzinga |
Continuous Manufacturing for Small Molecule APIs Industry Research 2026 - Global Market Size, Share, Trends, Opportunities, and Forecasts, 2021-2025 & 2026-2031January 28 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 0 | 0 | 0 | -2.5M | -2.5M | -0.580 |
| Q2 '25 | 0 | 700 | -700 | -2.7M | -2.8M | -0.820 |
| Q1 '25 | 0 | 610 | -610 | -3.2M | -3.3M | -1.060 |
| Q4 '24 | 6,400 | 3,200 | 3,200 | -3M | -3.7M | -1.140 |
| Q3 '24 | -6,400 | 3,200 | -1,600 | -1.7M | -1.9M | -0.780 |
Insider Transactions View All
| SCHABER CHRISTOPHER J filed to buy 15,511 shares at $1.3. October 3 '25 |
| Straube Richard filed to buy 8,000 shares at $0.5. May 18 '22 |
| SCHABER CHRISTOPHER J filed to buy 90,095 shares at $0.4. May 18 '22 |
Similar companies
Read more about Soligenix (SNGX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews & linkedin employees.
FAQ - Soligenix
The Market Cap of Soligenix is $11M.
Currently, the price of one share of Soligenix stock is $1.09.
The SNGX stock price chart above provides a comprehensive visual representation of Soligenix's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Soligenix shares. Our platform offers an up-to-date SNGX stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Soligenix (SNGX) does not offer dividends to its shareholders. Investors interested in Soligenix should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Soligenix are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
